LOCATELLI, ALESSIA
LOCATELLI, ALESSIA
Dipartimento di Scienze Biomediche per la Salute
Cellular mechanisms regulating uPA in hormone refractory prostate cancer : role of suPAR, a solubile form of Urokinase Plasminogen-Activator Receptor
2007-11-01 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Estrogen receptor β and the progression of prostate cancer : role of 5{alpha}-androstane-3β,17β-diol
2010-07-28 D. Dondi, M. Piccolella, A. Biserni, S. Della Torre, B. Ramachandran, A. Locatelli, P. Rusmini, D. Sau, D. Caruso, A. Maggi, P. Ciana, A. Poletti
MET RECEPTORS INDUCE SAM68-DEPENDENT CELL MIGRATION BY ACTIVATION OF ALTERNATE ERK FAMILY MEMBERS.
2010-12-20 A. Locatelli
Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors
2010-09-01 C. Festuccia, D. Dondi, M. Piccolella, A. Locatelli, G.L. Gravina, V. Tombolini, M. Motta
Role of a soluble form of urokinase plasminogen-activator receptor in the control of human prostate cancer cell growth and invasion
2008-01-01 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi
Role of Ozarelix in the control of proliferation, migration and invasion of human prostate cancer cell lines
2008-02-01 C. Festuccia, M. Piccolella, A. Locatelli, M. Bologna, M. Motta, D. Dondi
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
2008-01-01 M. Piccolella, C. Festuccia, D. Millimaggi, A. Locatelli, M. Bologna, M. Motta, D. Dondi